Upload

Loading...

  1. 153

    Yoseline's story -- USA

  2. 154

    Complex realities of global healthcare

  3. 155

    Novartis CEO Joe Jimenez: What do you tell a team that has failed?

  4. 156

    Each Voice Counts - The Experts

  5. 157

    The voice of advanced breast cancer patients on The Balancing Act® show

  6. 158

    The Next Generation Scientist 2012

  7. 159

    Novartis CEO Joe Jimenez: The best advice I ever got

  8. 160

    Each Voice Counts - The Family

  9. 161

    Periodic fever syndromes

  10. 162

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  11. 163

    A lifelong challenge: periodic fever syndromes

  12. 164

    Connections

  13. 165

    Each Voice Counts - The Women: Part 1

  14. 166

    Each Voice Counts - The Women: Part 2

  15. 167

    Unanswered questions about living with advanced breast cancer

  16. 168

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  17. 169

    Novartis International Biotechnology Leadership Camp 2012

  18. 170

    Journey of Chronic Myeloid Leukemia (CML)

  19. 171

    A look at the past decade in GIST: Chapter 6

  20. 172

    A look at the past decade in GIST: Chapter 5

  21. 173

    A look at the past decade in GIST: Chapter 4

  22. 174

    Vision loss due to Retinal Vein Occlusion (RVO)

  23. 175

    Vision loss due to Diabetic Macular Edema (DME)

  24. 176

    Vision loss due to wet age-related macular degeneration (wet AMD)

  25. 177

    A look at the past decade in GIST: Chapter 3

  26. 178

    Building the next generation of scientists

  27. 179

    A look at the past decade in GIST: Chapter 2

  28. 180

    A look at the past decade in GIST: Chapter 1

  29. 181

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  30. 182

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  31. 183

    Advanced breast cancer 101

  32. 184

    The mTOR pathway in ER+ advanced breast cancer

  33. 185

    Life in a Circle

  34. 186

    Understanding advanced breast cancer

  35. 187

    A Gift for Living

  36. 188

    The Villages Miles Away

  37. 189

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  38. 190

    Innovating to help eliminate malaria

  39. 191

    Malaria milestone video message

  40. 192

    Leo and Kya, friends against malaria

  41. 193

    The need for progress: what if?

  42. 194

    The myelofibrosis educational journey

  43. 195

    Understanding the progression of myelofibrosis

  44. 196

    Understanding the management of myelofibrosis

  45. 197

    The myelofibrosis disease burden

  46. 198

    The disease pathway associated with myelofibrosis

  47. 199

    New research developments in myelofibrosis

  48. 200

    Delivery of child-friendly antimalarial hits the 100 million mark

  49. 201

    Treating India's Leprosy patients

  50. 202

    Treating leprosy, caring for patients

  51. 203

    "SMS for Life" is expanding

  52. 204

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  53. 205

    Critical issues facing the advanced breast cancer patient community

  54. 206

    Advice to newly diagnosed advanced breast cancer patients

  55. 207

    Insight into the advanced breast cancer patient journey

  56. 208

    Pioneering an innovative social business model to fight malaria

  57. 209

    New media: drivers of democratization and development?

  58. 210

    What is it like living with myelofibrosis (MF)?

  59. 211

    What is the prognosis of myelofibrosis (MF)?

  60. 212

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  61. 213

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  62. 214

    What is myelofibrosis (MF)?

  63. 215

    How is the patient journey for advanced breast cancer patients different?

  64. 216

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  65. 217

    What is progression free survival and why is it important?

  66. 218

    What guidance do you give patients and family coping with advanced breast cancer?

  67. 219

    What insights can you share with newly diagnosed patients?

  68. 220

    Molecular pathways:The future of research at NIBR

  69. 221

    The importance of organ donation

  70. 222

    Novartis BioCamp 2011 (German)

  71. 223

    Novartis BioCamp 2011 (French)

  72. 224

    How is research in advanced breast cancer evolving?

  73. 225

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  74. 226

    What can a patient expect if diagnosed with advanced breast cancer?

  75. 227

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  76. 228

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  77. 229

    How does the advanced breast cancer treatment journey differ for patients?

  78. 230

    Novartis Be Healthy

  79. 231

    Novartis BioCamp 2011

  80. 232

    A sign from above

  81. 233

    Charlie

  82. 234

    Happy endings

  83. 235

    Herpes #1

  84. 236

    Herpes it's black and white

  85. 237

    Herpes the Ninja virus

  86. 238

    Magical elves with HSV

  87. 239

    Open happiness

  88. 240

    Play it smart

  89. 241

    Quarantine

  90. 242

    Strings

  91. 243

    Ah! Real herpes

  92. 244

    Down there

  93. 245

    Don't let herpes put you off

  94. 246

    Arogya Parivar: A social business model to improve health in rural India

  95. 247

    Living with multiple myeloma

  96. 248

    What are the symptoms of myelofibrosis (MF)?

  97. 249

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  98. 250

    Animals & Research: Think how far we've come

  99. 251

    SMS for Life

to add this to Watch Later

Add to